v3.24.1.u1
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Net revenue        
Total net revenue     $ 1,224 $ 3,309
Costs and expenses        
Cost of revenue $ 329 $ 694 1,620 2,852
Research and development 1,562 3,417 11,044 12,193
Selling, general and administrative 15,663 5,794 24,104 11,978
Loss from operations (17,269) (9,226) (35,544) (23,714)
Interest expense 857 83 3,355 343
Change in fair value of earnout liability (24,764)    
Change in fair value of PIPE make-whole liability 2,904    
Change in fair value of private warrants 60    
Change in fair value of SAFEs 10 50 655 83
Merger-related transaction costs expensed 4,009    
Loss before income taxes (345) (9,359) (39,554) (24,140)
Provision (benefit) for income taxes (1,280) 31 67 (273)
Net income (loss) and comprehensive income (loss) $ 935 $ (9,390) $ (39,621) $ (23,867)
Net income (loss) per common share:        
Diluted (in Dollars per share) $ 0.04 $ (0.76) $ (2.71) $ (2.25)
Weighted-average common shares outstanding:        
Diluted (in Shares) 23,316,071 12,379,480 14,612,600 10,620,614
Net loss per common share, basic (in Dollars per share) $ 0.04 $ (0.76) $ (2.71) $ (2.25)
Weighted-average common shares outstanding, basic (in Shares) 18,617,656 12,379,480 14,612,600 10,620,614
Product sales        
Net revenue        
Total net revenue $ 285 $ 679 $ 1,224 $ 2,859
License revenue        
Net revenue        
Total net revenue     $ 450